Eble JN, Sauter G., Epstein JI, Sesterhenn IA - iarc
Eble JN, Sauter G., Epstein JI, Sesterhenn IA - iarc
Eble JN, Sauter G., Epstein JI, Sesterhenn IA - iarc
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Squamous neoplasms<br />
T.H. Van der Kwast<br />
Definition<br />
Tumours with squamous cell differentiation<br />
involving the prostate.<br />
ICD-O codes<br />
Adenosquamous carcinoma 8560/3<br />
Squamous cell carcinoma 8070/3<br />
Epidemiology<br />
The incidence of squamous cell carcinoma<br />
of the prostate is less than 0.6% of all<br />
prostate cancers {1814,1861}. There are<br />
70 cases reported in literature. Even more<br />
rare is adenosquamous carcinoma of the<br />
prostate, with about 10 cases reported so<br />
far. For primary prostatic squamous cell<br />
carcinoma an association with<br />
Schistosomiasis infection has been<br />
described {44}. Approximately 50% of<br />
adenosquamous carcinomas may arise in<br />
prostate cancer patients subsequent to<br />
endocrine therapy or radiotherapy {179}.<br />
Localization<br />
Squamous cell carcinomas may originate<br />
either in the periurethral glands or in the<br />
prostatic glandular acini, probably from the<br />
lining basal cells, which show a divergent<br />
differentiation pathway {606,931}.<br />
Adenosquamous carcinomas are probably<br />
localized more commonly in the transition<br />
zone of the prostate accounting for their<br />
more frequent detection in transurethral<br />
resection specimens {179,2613}.<br />
Clinical features<br />
Most, if not all pure squamous cell carcinomas<br />
become clinically manifest by<br />
local symptoms such as urinary outflow<br />
obstruction, occasionally in association<br />
with bone pain and haematuria. Most<br />
patients have at the time of diagnosis<br />
metastatic disease, and bone metastases<br />
are osteolytic. PSA levels are not<br />
typically elevated. The age range of<br />
patients is between 52 and 79 years<br />
{1861}. Hormone treatment and<br />
chemotherapy are not effective, except<br />
for a single case with non-progressive<br />
disease after local irradiation and systemic<br />
chemotherapy {2657}. In cases of<br />
organ-confined disease, radical prostatectomy<br />
or cystoprostatectomy, including<br />
total urethrectomy is recommended<br />
{1513}.<br />
Adenosquamous carcinomas may be<br />
detected by increased serum PSA, but<br />
more typically by obstruction of the urinary<br />
outflow, requiring transurethral<br />
resection {179}. Patients may also present<br />
with metastatic disease. A proportion<br />
of cases show an initial response to hormone<br />
therapy {32,1176}.<br />
Tumour spread<br />
Both squamous cell carcinomas and<br />
adenosquamous carcinomas tend to<br />
metastasize rapidly with a predilection<br />
for the skeletal bones {841,1861}.<br />
Histopathology<br />
By definition pure squamous cell carcinoma<br />
does not contain glandular features<br />
and it is identical to squamous cell<br />
carcinoma of other origin. With rare<br />
exception, it does not express PSA or<br />
PAP {1861,2657}. Primary prostatic squamous<br />
cell carcinoma must be distinguished<br />
on clinical grounds from secondary<br />
involvement of the gland by bladder<br />
or urethral squamous carcinoma.<br />
Histologically, squamous cell carcinoma<br />
must be distinguished from squamous<br />
metaplasia as may occur in infarction or<br />
after hormonal therapy.<br />
Adenosquamous carcinoma is defined<br />
by the presence of both glandular (acinar)<br />
and squamous cell carcinoma components.<br />
Some authors considered the<br />
possibility that adenosquamous carcinomas<br />
consist of collision tumours with a de<br />
novo origin of adenocarcinoma and<br />
squamous cell carcinoma {841}. The<br />
glandular tumour component generally<br />
expresses PSA and PAP, whereas the<br />
squamous component displays high<br />
molecular weight cytokeratins {179}.<br />
A<br />
B<br />
Fig. 3.79 A Cross section of squamous cell carcinoma. B Squamous cell carcinoma of the prostate with focal keratinization.<br />
Squamous neoplasms 205